local_hospital

BKS Research Kft.

Address
lock Available on a paid plan

Cardiovascular Diseases and Metabolic Research

At BKS Research Kft. in Hatvan, Hungary, a major share of the clinical research focuses on cardiovascular disease and nutritional and metabolic disorders. The studies are designed to assess new approaches for reducing heart-related events, improving heart failure care, and supporting better control of conditions linked to obesity, type 2 diabetes, and hypertension.

  • Testing new treatments aimed at lowering the risk of cardiovascular events in people with established or high-risk heart disease
  • Evaluating therapies for heart failure, including forms with preserved and reduced pumping function
  • Studying treatment options for obesity, overweight, and related cardiometabolic conditions

This research area combines prevention and treatment goals, with a strong emphasis on improving outcomes for patients at risk of serious heart and metabolic complications.

Respiratory Tract Diseases

The site also supports studies in respiratory medicine, especially for chronic obstructive pulmonary disease, asthma, and bronchiectasis. These trials are centered on easing breathing problems, reducing flare-ups, and comparing inhaled therapies to find more effective and better-tolerated options.

  • Assessing treatments for COPD to improve lung function and reduce exacerbations
  • Comparing inhaled therapies for asthma control and airway safety
  • Investigating options for bronchiectasis to help lower pulmonary worsening over time

Overall, the respiratory portfolio is aimed at improving symptom control and long-term disease management in common and chronic lung diseases.

Digestive System Diseases and Inflammatory Conditions

Research at this facility includes gastroenterology, with trials in ulcerative colitis that explore how well new treatments can induce remission and relieve intestinal inflammation. The goal is to improve day-to-day disease control for patients living with active bowel disease.

  • Evaluating therapies for ulcerative colitis to achieve clinical remission
  • Focusing on better control of digestive tract inflammation and related symptoms
  • Supporting studies that aim to improve treatment effectiveness in chronic intestinal disease

This area reflects a practical focus on symptom relief, remission, and improved quality of life for people with inflammatory bowel disease.

Nervous System Diseases and Pain-Related Research

The site is involved in studies of diabetic sensorimotor polyneuropathy, a nerve complication associated with diabetes that can cause pain, numbness, and loss of sensation. These trials are intended to assess whether new combined treatments can better ease symptoms and support nerve-related function.

  • Investigating symptom relief in diabetic neuropathy
  • Comparing treatment strategies for nerve pain and sensory problems
  • Exploring improved care for diabetes-related neurological complications

This research area highlights the site’s interest in finding more effective ways to manage chronic neuropathic symptoms linked to metabolic disease.

Skin and Connective Tissue Diseases

Another important field at BKS Research Kft. is the study of chronic venous ulcers, where the focus is on helping stubborn wounds heal and improving local treatment options. These trials are designed to evaluate whether new therapies can support wound closure in patients whose ulcers have not responded well to standard care.

  • Testing treatments for non-healing venous leg ulcers
  • Assessing wound closure and treatment safety
  • Exploring better care for chronic skin and tissue damage

The work in this area is focused on practical healing outcomes and improving options for patients with difficult-to-treat wounds.

Site Overview

assignment
26
connected trials
corporate_fare
16
sponsors
science
28
IMPs

Activity Indicator

Last 6 months

2
Trials started
-67% vs previous period.
6
Trials started 6–12 months ago
26
Total trials linked
Highly Active
trending_downDeclining-67%
1
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 3 of 7 therapeutic areas and 15 of 28 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
12
Sponsors (total)
16
Active sponsors
8

Sponsor Network

Top 8 by active trials.

lock +7 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +6 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 332 other sites in Hungary

description
Trial volume
26
Outperforms 85% of sites
public
Therapeutic diversity
7areas
Outperforms 88% of sites
groups
Sponsor diversity
16sponsors
Outperforms 87% of sites

Therapeutic Area Benchmark — Hungary

Select a therapeutic area to compare against other sites in Hungary.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Hungary

Market Share

Country: Hungary

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in BKS Research Kft.

lock Showing 1 of 26 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 28 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Beclometasone Dipropionate Anhydrous3Unknown2022-04-222026-04-13

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.